211 related articles for article (PubMed ID: 35713558)
1. Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature.
Menichini D; Ughetti C; Monari F; Di Vinci PL; Neri I; Facchinetti F
Gynecol Endocrinol; 2022 Aug; 38(8):623-631. PubMed ID: 35713558
[No Abstract] [Full Text] [Related]
2. The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network Meta-analysis.
Zhang J; Xing C; Zhao H; He B
Gynecol Endocrinol; 2021 Dec; 37(12):1063-1071. PubMed ID: 33988478
[TBL] [Abstract][Full Text] [Related]
3. Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review.
Iervolino M; Lepore E; Forte G; Laganà AS; Buzzaccarini G; Unfer V
Nutrients; 2021 May; 13(5):. PubMed ID: 34063339
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
[TBL] [Abstract][Full Text] [Related]
6. D-Chiro-inositol and PCOS: between myth and reality. The never-ending story.
Cianci A; Vitale SG
Int J Food Sci Nutr; 2022 Aug; 73(5):565-570. PubMed ID: 35057707
[TBL] [Abstract][Full Text] [Related]
7. Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome.
Alesi S; Ee C; Moran LJ; Rao V; Mousa A
Adv Nutr; 2022 Aug; 13(4):1243-1266. PubMed ID: 34970669
[TBL] [Abstract][Full Text] [Related]
8. The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.
Fedeli V; Catizone A; Querqui A; Unfer V; Bizzarri M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047265
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study.
Zhao JF; Li BX; Zhang Q
Ann Palliat Med; 2021 Jan; 10(1):169-183. PubMed ID: 33545754
[TBL] [Abstract][Full Text] [Related]
10. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
Pizzo A; Laganà AS; Barbaro L
Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
Menichini D; Facchinetti F
Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
[TBL] [Abstract][Full Text] [Related]
13. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
Laganà AS; Garzon S; Casarin J; Franchi M; Ghezzi F
Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
[TBL] [Abstract][Full Text] [Related]
14. Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients.
Stracquadanio M; Ciotta L; Palumbo MA
Gynecol Endocrinol; 2018 Jun; 34(6):495-501. PubMed ID: 29265900
[TBL] [Abstract][Full Text] [Related]
15. Inositols in PCOS.
Kamenov Z; Gateva A
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260918
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
Hu X; Wang W; Su X; Peng H; Tan Z; Li Y; Huang Y
PeerJ; 2023; 11():e16410. PubMed ID: 38025704
[TBL] [Abstract][Full Text] [Related]
17. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
Gateva A; Unfer V; Kamenov Z
Gynecol Endocrinol; 2018 Jul; 34(7):545-550. PubMed ID: 29309199
[TBL] [Abstract][Full Text] [Related]
18. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
Unfer V; Porcaro G
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
[TBL] [Abstract][Full Text] [Related]
19. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome.
Jamilian M; Shojaei A; Samimi M; Afshar Ebrahimi F; Aghadavod E; Karamali M; Taghizadeh M; Jamilian H; Alaeinasab S; Jafarnejad S; Asemi Z
J Affect Disord; 2018 Mar; 229():41-47. PubMed ID: 29306057
[TBL] [Abstract][Full Text] [Related]
20. Inositol as putative integrative treatment for PCOS.
Genazzani AD
Reprod Biomed Online; 2016 Dec; 33(6):770-780. PubMed ID: 27717596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
